Avidity Biosciences
RNA
#1823
Rank
C$14.98 B
Marketcap
C$99.47
Share price
0.37%
Change (1 day)
124.06%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: C$14.98 Billion

As of December 2025 Avidity Biosciences has a market cap of C$14.98 Billion. This makes Avidity Biosciences the world's 1823th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025C$14.98 B190.74%
2024C$5.15 B442.41%
2023C$0.95 B-52.51%
2022C$2.00 B40.87%
2021C$1.42 B16.34%
2020C$1.22 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Avidity Biosciences was reported to be:

C$14.98 Billion
by Nasdaq info icon info icon
C$14.98 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
C$8.25 B-44.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.13 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$2.93 B-80.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$4.01 B-73.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.16 B-98.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
C$15.07 B 0.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$196.32 B 1,209.87%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$135.75 B 805.79%๐Ÿ‡ฌ๐Ÿ‡ง UK